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Simian immunodeficiency virus (SIV)-related neuropathogenesis has been observed in 90% of pig-tailed macaques infected with strain
SIVsmmFGb, making it an excellent system for studying human immunodeficiency virus (HIV)-associated neurological disease. To
investigate the genetics of SIV neurovirulence, infectious molecular clones were generated from the brain of a SIVsmmFGb-infected pig-
tailed macaque. One clone, BPZm.12, displayed a macrophage-restricted phenotype not previously described; this clone replicated to high
levels in macrophages, but did not replicate in peripheral blood mononuclear cells (PBMC) until at least 21 days postinfection. Sequence
analysis of the env gene of BPZm.12 revealed the substitution of a serine residue for a highly conserved proline residue at position 629 in
gp41. A mutant clone, which contained the conserved proline to serine (BPZm.12-629P), was able to replicate in both macrophages and
PBMC without delay. A mutant of an unrelated dual tropic molecular clone PBj6.6, substituting proline for serine (PBj6.6-629S), replicated
to high levels in macrophages, but did not replicate in PBMC at any time point. These data indicated that a single determinant in gp41 of an
SIV clone changed its phenotype from macrophage tropic to dual tropic.
D 2004 Elsevier Inc. All rights reserved.Keywords: SIV; Macrophage; Tropism; Molecular clone; Neuropathogenesis; Replication
Introduction function as well as behavioral changes (Dewhurst et al.,An estimated 40 million people worldwide are currently
infected with human immunodeficiency virus type 1 (HIV-
1), the etiological agent of acquired immune deficiency
syndrome (AIDS) (World Health Organization, 2002). In
addition to AIDS, HIV infection is associated with other
sequelae, one of the most devastating of which is HIV-
associated neurological disease (reviewed in Dewhurst et
al., 1996; Zink et al., 1999). HIV-associated neurological
disease affects up to 60% of AIDS patients, and is charac-
terized by the progressive loss of motor and cognitive822/$ - see front matter D 2004 Elsevier Inc. All rights reserved.
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ail address: fnovembr@rmy.emory.edu (F.J. Novembre).1996; Gonzalez-Scarano, 1998; Zink et al., 1999). The
major clinical correlate of HIV-associated neurological
disease is HIV encephalitis, which is associated with the
presence of viral antigens in the brain, multinucleated giant
cell formation, astrocytosis, increased apoptosis of neurons,
and resulting neuronal dysfunction and loss (Gartner, 2000;
Wiley and Achim, 1994). The presence of virus in the brain
is a prerequisite for HIV encephalitis (Gartner, 2000), but
viral determinants for replication within the central nervous
system (CNS) have not been fully elucidated.
HIV neuropathogenesis likely results from of a combi-
nation of host factors and viral virulence factors. The main
targets of HIV infection in the brain are cells of macrophage
origin, which include infiltrating macrophages and resident
microglial cells (reviewed in Gartner, 2000; Griffin, 1997).
Not surprisingly, macrophage tropism is necessary, although
not sufficient, for neurovirulence (Flaherty et al., 1997;
A.A. Glenn, F.J. Novembre / Virology 325 (2004) 297–307298Mankowski et al., 1997). Virus isolated from patients with
HIV-associated neurological disease is uniformly macro-
phage-tropic, as is virus isolated from the brain of macaques
with simian immunodeficiency virus (SIV)-associated neu-
rological disease. Determinants of viral tropism in the both
SIVand HIV have been shown to reside within the envelope
glycoprotein (Env) (Mori et al., 1992, 1993). In fact,
macrophage tropism for SIVmac239-derived viruses has
been linked to only a few amino acids in Env (Mori et al.,
1992); very little is known about the determinants for
macrophage tropism of mangabey-derived isolates. Clearly,
cell tropism and the viral determinants of tropism are
important areas of study in HIV neuropathogenesis as well
as general lentivirus pathogenesis.
We previously characterized a highly neuropathogenic
SIV, initially derived from a naturally infected sooty
mangabey monkey (Novembre et al., 1998; O’Neil et al.,
2004). This isolate, termed SIVsmmFGb, induces neuro-
pathogenic infection in greater than 90% of infected pig-
tailed macaques. We believe SIVsmmFGb studies will
provide important information regarding neuroinvasion
and neuropathogenesis of lentiviruses. To investigate the
molecular basis of SIV pathogenesis in the CNS, we
generated a recombinant molecular clone of the SIV
genome with the 3V half derived from the brain of a pig-
tailed macaque with a neuropathogenic infection. The
replication studies of this clone revealed a solely macro-
phage-tropic phenotype not previously reported in HIV/
SIV literature. Genetic analysis and mutagenesis studies
showed that a single amino acid residue in Env determined
the unusual phenotype of this cloned virus. This report will
discuss the results of this study and their implications for
lentivirus cell tropism.Results
Generation of a molecular clone of SIV
One of the main goals of this project was to gen-
erate infectious molecular clones of neuropathogenic
SIVsmmFGb. We previously described the derivation of a
molecular clone of SIVsmmFGb from the mesenteric lymphTable 1
Comparison between BPZm.12 and other SIVsmm clones
Molecular
clone
Original inoculum Source of mo
PBj6.6 SIVsm9 virus into pig-tailed macaque PBj pig-tailed ma
PGm5.3 SIVsmmFGb whole blood into pig-tailed
macaque PGm
pig-tailed ma
BPZm.12 SIVsmmFGb virus (CSF isolate) into
pig-tailed macaque PZm
5V half from
from pig-taile
*Pairwise alignments between selected sequences were performed using the M
homologies, lower values represent percentage of divergence.node of an infected pig-tailed macaque; the clone was
termed PGm5.3 (Novembre et al., 1998). The replication
characteristics of this clone are shown in Table 1. However,
PGm5.3 does not induce neurovirulent infection in a high
percentage of pig-tailed macaques. With a neuropathogenic
molecular clone of SIVsmmFGb, determinants of neuro-
virulence could be investigated. We took two pieces of
information into account for cloning strategy: the 3V half of
an SIV clone contains the determinants for neurovirulence
in SIVmac (Mankowski et al., 1997); and passage through
the CNS generally increases the neurovirulence of an SIV
strain (Sharma et al., 1992). Therefore, we generated clones
using genomic DNA from the brain of pig-tailed macaque
PZm (Table 1). PZm was infected with the ROn2/CSF
isolate of SIVsmmFGb, originally cultured from the cerebral
spinal fluid (CSF) of macaque ROn2 as described previ-
ously (Novembre et al., 1998). The ROn2/CSF isolate is
dual tropic and highly neurovirulent in macaques. PZm
rapidly progressed to AIDS with SIV encephalitis, including
a high virus load in the brain at the time of death; 7.5
months postinfection (Novembre et al., 1998).
To generate a full-length molecular clone, the 3V half of
the SIV genome was amplified by PCR from genomic DNA
isolated from the brain of PZm. The amplification product
was cloned directly into a plasmid carrying the 5V half of
PGm5.3 (5V PGm5). The 5V half plasmid and 3V half PCR
product were joined at the conserved BclI site, similar to our
previous cloning efforts (Novembre et al., 1993, 1998).
Infectivity of full-length clones was tested by transfection
into CEMx174 cells and HEK293T cells. The following
results describe the in vitro characterization of one such
clone, BPZm.12.
Replication phenotype of BPZm.12
While transfection of the BPZm.12 plasmid into
CEMx174 cells yielded no infectious virus even after 28
days in culture, transfection into HEK293T cells produced
an RT-positive supernatant within 48 h. These results
suggested a possible modified viral tropism. Because virus
in the brain is invariably macrophage tropic, the infectivity
of this clone was tested in macrophages. Therefore, the
supernatants of transfected HEK29T cells were used tolecular clone Tropism, pathogenicity Amino acid
homology of
Env compared
to BPZm.12* (%)
caque PBMC dual, extremely high 88.7
caque lymph node dual, low 93.9
PGm5.3, 3V half
d macaque brain
solely macrophage,
undetermined
egAlign program (DNASTAR). Higher values represent percentage of
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derived virus was able to replicate readily and was grown in
macrophages for further study.
We first determined the replication kinetics of BPZm.12
in pig-tailed macrophages and PBMC in vitro. BPZm.12
was compared to two control clones: PGm5.3, the cognate
variant SIVsmmFGb molecular clone; and PBj6.6, an un-
related, highly pathogenic molecular clone derived from a
pig-tailed macaque (Table 1). Fig. 1A shows a representa-
tive experiment where the growth of BPZm.12 and two
other cloned viruses was investigated in monocyte-derived
macrophages. Replication of BPZm.12 was detected by 7
days postinfection, levels of virus production increased with
time. The replication kinetics of this virus was similar to the
other two clones tested (PBj6.6 and PGm5.3), but BPZm.12
consistently showed higher levels of replication at the end of
the monitoring period. When all replicates of this experi-
ment were combined, it was found that BPZm.12 replicated
to higher levels than the related cloned virus, PGm5.3Fig. 1. Replication kinetics of BPZm.12 and control clones in pig-tailed mac
macrophages were infected with 10ng p27 equivalents of virus derived from molec
the indicated days by determining the levels of RT activity in the supernatant by PE
PBMC were infected with 10 ng p27 equivalents of BPZm.12 or PGm5.3 virus. V
28 days postinfection (BPZm.12-D28) was harvested and titered for the amou
equivalents of BPZm.12-D28 or PBj6.6 virus. Virus replication was assessed as ab
virus. Virus replication was assessed as above. The experiments shown are repre(P < 0.05 as determined by a one-tailed t test). Additionally,
in each individual experiment, BPZm.12 replicated to
higher levels than PBj6.6, but the overall difference was
not statistically significant, likely due to the variability
observed in vitro PBj6.6 replication studies.
In contrast to the results in macrophage cultures,
BPZm.12 replication in stimulated pig-tailed macaque
PBMC was severely delayed (Fig. 1B), with no evidence
of viral replication until at least 21 days after infection. In
some PBMC samples, BPZm.12 showed no growth at any
time point (data not shown). These results differed greatly
from the other clones tested, which showed growth by day
3 postinfection. Additionally, when tested in cell lines,
BPZm.12 was unable to replicate in CEMx174 (Fig. 1D),
HUT78 cells, or U937 monocytic cell line (data not
shown).
To investigate the virus replicating after day 21 in
BPzm.12-infected PBMC cultures, we took supernatant
samples from day 28 after infection (termed BPZm.12-aque macrophages, PBMC, and CEMX174 cells. (A) Monocyte-derived
ular clones BPZm.12, PBj6.6, or PGm5.3. Virus replication was assessed on
G-RT assay as described. (B) 2  107 ConA-stimulated pig-tailed macaque
irus replication was assessed as above. (C) Virus replicating in PBMC after
nt of p27 equivalents. Stimulated PBMC were infected with 10 ng p27
ove. (D) 1  107 CEMX174 cells were infected with BPZm.12 or PGm5.3
sentative of at least three separate experiments for each assay.
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these experiments are shown in Fig. 1C. Interestingly, in
contrast to the original BPZm.12 virus stock, BPZm.12-D28
virus showed immediate replication in the PBMC. The
growth kinetics of BPZm.12-D28 was similar to other
viruses tested and replication was detected by day 3 post-
infection. When tested on monocyte-derived macrophages,
BPZm.12-D28 replicated in macrophages with similar ki-
netics as BPZm.12 stock (data not shown). These data
suggest that BPZm.12 switched from macrophage tropism
to expanded tropism following culture in PBMC.
Both T cells and monocytes are possible targets for SIV
infection in PBMC culture. Immunomagnetic separation
was used to isolate specific cell types to determine which
cells in bulk PBMC are targets for BPZm.12 replication
after 21 days in culture. First, bulk PBMCs were separated
into CD3+ and CD3 populations, with greater than 96%
efficiency (Fig. 2). These cells were used in the replication
studies shown in Fig. 2. BPZm.12 replicated in CD3+ cells
with the same kinetics and to the same levels as in bulkFig. 2. Replication of BPZm.12 in PBMC-derived CD3+ and CD3 cell populati
CD3 populations by immunomagnetic separation. (A) FACS analysis of CD3 se
cell populations were infected with 10 ng p27 equivalents of BPZm.12 or PBj6.6
cell supernantant, using PEG-RT assay. Results are representative of three separaPBMC, indicating that the target cells for the replication of
BPZm.12 in PBMC are CD3+ cells. Neither BPZm.12 nor
the control virus, PBj6.6, was able to replicate in CD3
cells (data not shown). These data suggested that T cells, not
monocytes, are the targets for BPZm.12 replication after 21
days in PBMC culture. To confirm this hypothesis, we
depleted bulk PBMC of CD14+ cells to remove monocytes
from the PBMC population. BPZm.12 replicated in
CD14PBMC with the same kinetics and to the same levels
as in bulk PBMC (data not shown).
In summary, replication studies indicated that
BPZm.12 replicated to very high levels in macrophages,
but did not replicate in CD3+ cells until after prolonged
culture in PBMC. These data confirmed that BPZm.12
switched from macrophage tropism to expanded tropism
during culture in PBMC. An HIV or SIV clone with
strictly macrophage-tropic phenotype has not been de-
scribed previously. Because of this unique result, we
investigated the molecular determinants of BPZm.12
unusual tropism.ons. Freshly isolated pig-tailed macaque PBMC were sorted into CD3+ and
paration showing efficient PBMC sorting. (B) Untreated (whole) and CD3+
virus. Replication was assessed by measuring the RT activity present in the
te experiments.
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To investigate the basis of the unusual phenotype of
BPzm.12, the DNA sequence of the entire 3V half of
BPZm.12 was determined. As was stated before, the 5V half
was derived from PGm5.3, thus, it is not implicated in the
unique replication profile of this virus. Initial analysis of
deduced amino acid sequences of SIV proteins revealed
strong homology between BPZm.12 and other mangabey-
derived SIV clones, especially its cognate variant, PGm5.3.
The homology between BPZm.12, PGm5.3, and PBj6.6 is
shown in Table 1. Because BPZm.12-D28 displayed a dual
tropic phenotype, the sequence in the env gene was deter-
mined and compared to that of BPZm.12.
The truncated transmembrane gp41 protein is not
responsible for the unusual phenotype of BPZm.12
One unique feature of BPZm.12 was immediately appar-
ent after sequence analysis—BPZm.12 env contained a
premature stop codon, resulting in the truncation of the
envelope glycoprotein gp41 at position 738, 16 amino acids
after the transmembrane domain. Truncation of Env is not
uncommon in SIV clones, although truncation-inducing
mutations have previously been attributed to in vitro culture
A.A. Glenn, F.J. NovembreFig. 3. Alignment of SIVenv nucleotide sequences and deduced amino acid sequen
molecular clone, BPZm.12 molecular clone, RT-PCR product of BPZm.12 virus sto
(B) Nucleotide alignment of BPZm.12 molecular clone. RT-PCR product of BPZm
single nucleotide change in BPZm. 12-D28 coincident with observed replication in
with other SIV isolates. The conserved proline at position 629 is boxed.in human T cells lines (Hirsch et al., 1989; Kodama et al.,
1989; Luciw et al., 1998). Because BPZm.12 was derived
directly from the brain, it represented an in vivo phenom-
enon. Only one other study has demonstrated Env truncation
in vivo (Ryzhova et al., 2002). Interestingly, we found that
approximately 30% (n = 17) of the clones derived from the
brain of pig-tailed macaque PZm contained truncations, but
no clones derived from the mesenteric lymph node of this
animal contained truncations in Env (data not shown).
Env truncations are thought to facilitate replication in
macrophages (Mori et al., 1992); therefore, we investigated
the contribution of the Env truncation to the unusual
phenotype of BPZm.12. To examine the role of the Env
truncation in BPZm.12 cell tropism, env clones were gen-
erated by RT-PCR from both BPZm.12 virus stock and
BPZm.12-D28 virus. The premature stop codon was con-
served in 100% of clones from BPZm.12-D28 (Fig. 3A),
suggesting that the truncation was not a contributing factor
in the change in tropism during PBMC culture.
Identification of the single molecular determinant involved
in BPZm.12 tropism
Further comparison of the env clones from BPZm.12 and
BPZm.12-D28 revealed only a single conserved nucleotideces. (A) Nucleotide and deduced amino acid sequence alignment of PGm5.3
ck, and RT-PCR product of day 28 supernatant codon in Env gp41 (boxed).
.12 virus stock, and RT-PCR product of BPZm.12-D28. Alignment reveals a
PBMC. (C) Alignment of deduced Env amino acid sequences of BPZm. 12
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clones analyzed (n = 20) contained a CCA codon in place of
a TCA codon at positions 1886–1888. This single nucleo-
tide substitution results in a deduced amino acid change
from serine to proline at position 629. Comparison to other
SIVmac and SIVsmm clones indicated that the proline at
position 629 is extremely well conserved and an extensive
search did not reveal any other SIV clones with a residue
other than proline at position 629 (Fig. 3C), suggesting that
the serine at position 629 may play a role in the tropism of
BPZm.12.
We tested our hypothesis that the 629S substitution is
responsible for the unusual tropism of BPZm.12 by gener-
ation and characterization of mutants of BPZm.12 and of an
unrelated control clone, PBj6.6. We chose to use PBj6.6 in
these experiments because of its lower homology to
BPZm.12 in Env and because of its unrelated origin. We
considered PGm5.3 too related in sequence and origin to
truly determine if the single amino acid change, 629S, was
responsible for the unusual tropism of BPZm.12.
Site-directed mutagenesis was used to replace the CCA
codon with the TCA codon, thereby substituting 629S with
629P, in BPZm.12. Conversely, we replaced the conservedFig. 4. Replication of BPZm.12, PBj6.6, and their respective mutants in pig-tailed
macrophages were infected with 10 ng p27 equivalents of virus derived from m
replication was assessed on the indicated days by determining the levels of RT act
stimulated pig-tailed macaque PBMC were infected with 10 ng p27 equivalents
above. (C) 2  107 ConA-stimulated pig-tailed macaque PBMC were infected
replication was assessed as above. (D) 1  107 CEMX174 cells were infected w
629S. Virus replication was assessed as above. The experiments shown are repreCCA codon with TCA in the highly infectious, dual tropic
clone PBj6.6. The resulting clones, BPZm.12-629P and
PBj6.6-629S, were used for in vitro replication studies.
As seen in Fig. 4A, BPZm.12-629P and PBj6.6-629S
were still able to replicate in monocyte-derived macro-
phages. Interestingly, BPZm.12 replicated to significantly
higher levels than BPZm.12-629P (P < 0.05 as determined
by a one-tailed t test). Additionally, PBj6.6-629S replication
to higher levels than PBj6.6 in each of three replication
studies in macrophages; although the differences showed a
marked trend, they were not statistically significant. These
results indicated that 629S might enhance the replication of
a clone in macrophages, although the reasons for this
enhancement remain unclear. When tested in PBMC,
BPZm.12-629P was able to immediately replicate in PBMC
(Fig. 4B), in contrast to the delay in kinetics observed in the
parental clone, BPZm.12. BPZm.12-629P replicated in
PBMC with normal kinetics, with virus growth detected
as early as day 3 postinfection. In contrast, the 629S
mutation in PBj6.6 completely abrogated the ability of
the virus to replicate in all PBMC samples tested (n = 5).
As shown in Fig. 4C, PBj6.6-629S did not replicate in
PBMC at any time point. These results showed that themacaque macrophages, PBMC, and CEMX174 cells. (A) Monocyte-derived
olecular clones BPZm.12, BPZm.12-629P, PBj6.6, or PBj6.6-629S. Virus
ivity in the supernatant by PEG-RT assay as described. (B) 2  107 ConA-
of BPZm.12, BPZm.12-629P, or PBj6.6. Virus replication was assessed as
with 10 ng p27 equivalents of BPZm.12, PBj6.6, or PBj6.6-629S. Virus
ith 10 ng p27 equivalents of BPZm.12, BPZm.12-629P, PBj6.6, or PBj6.6-
sentative of at least three separate experiments for each assay.
A.A. Glenn, F.J. Novembre / Virology 325 (2004) 297–307 303single mutation in gp41 is responsible for the unique
tropism of BPZm.12. BPZm.12-629S did not replicate in
the CEMx174 cell line (Fig. 4D), suggesting that the
determinants for replication in pig-tailed macaque cell
cultures are not the same as those for replication in
laboratory cell lines.
Site-directed mutagenesis was used to change BPZm.12
from macrophage tropic to dual tropic and PBj6.6 from dual
tropic to macrophage tropic in vitro. These data strongly
suggest that the proline at position 629 in Env was neces-
sary replication in T cells, but was not necessary for
replication in monocyte-derived macrophages. Because
PBj6.6 does not contain a truncated gp41, these data further
support our conclusion that the truncation found in
BPZm.12 does not affect its in vitro replication phenotype.
With these results, we have identified a single determinant
of expanded tropism in SIV.Discussion
The mechanisms involved in neuropathogenesis of
HIV and SIV infection are still not well understood.
Macrophage tropism is required for HIV and SIV repli-
cation in the CNS, and is defined by specific sequences
in the env gene (Gartner, 2000; Griffin, 1997; Mori et al.,
1992). While genetic determinants of macrophage tropism
have been defined in HIV-1 and SIVmac systems, mac-
rophage tropism alone is not sufficient for neuropathoge-
nicity (Flaherty et al., 1997; Mankowski et al., 1997).
The SIVsmmFGb/macaque model presents an excellent
tool for investigating neuropathogenic infection due to the
high incidence of neurological disease in infected animals
(Novembre et al., 1998). The study presented here
examines the unusual tropism of a molecular clone
derived from the brain of a SIVsmmFGb-infected pig-
tailed macaque presenting with neuropathogenic infection.
This clone, BPZm.12, showed a macrophage-restricted
phenotype in vitro. Only after prolonged culture in
PBMC was BPZm.12 replication detected in CD3+ cells.
The unusual tropism of this virus was mapped to a single
amino acid change at Env position 629 in gp41. The
change resulted in the replacement of a highly conserved
proline residue with a serine residue in BPZm.12.
The role of this single amino acid in the macrophage-
restricted phenotype of BPZm.12 was confirmed by both
sequence analysis and mutational analysis. First, virus
replicating in PBMC culture after 21 days (BPZm.12-
D28) was shown to contain a reversion of serine to the
conserved proline at position 629 in Env. Secondly, a
mutant of BPZm.12 containing a proline at this position
(BPZm.12-629P) was shown to immediately initiate rep-
lication in PBMC, while retaining its ability to replicate
in macrophages. Finally, a mutation of the dual tropic
PBj6.6 molecular clone containing a serine at Env
position 629 (PBj6.6-629S) was shown to replicate onlyin macrophages and not in PBMC cultures. Interestingly,
the proline to serine change appears to facilitate replica-
tion in macrophage cultures, as those clones containing a
629S residue replicated to consistently higher levels than
those containing a 629P residue.
As discussed above, macrophage tropism is necessary
for neurovirulence of HIV and SIV, most likely because
the main cell types supporting viral replication in the
brain are macrophages and microglia. We hypothesize
that virus replicating in the brain may evolve to increase
its ability to replicate in the relevant target cells. Current
investigations in our laboratory are now examining this
hypothesis.
In addition to this unusual mutation, BPZm.12 contained
a truncation in gp41. While gp41 truncation itself is not
unusual, the truncations have previously been attributed to
the adaptation of virus to cell lines (Hirsch et al., 1989;
Kodama et al., 1989; Luciw et al., 1998). While these
truncations have mainly been observed in vitro, one other
report has documented the appearance of truncated SIV Env
in vivo (Ryzhova et al., 2002). Approximately 30% of the
genotypes found in the brain of animal PZm contained
truncations, but no truncations were detected in the lymph
node (data not shown).
Taken together, these data strongly suggest a separate
evolution of SIV in the brain of macaque PZm. Several
studies have examined viral genotype in reference to neu-
rological dysfunction in the brains of AIDS patients and
have revealed variations in env sequences in brain isolates
compared to lymphoid isolates (Cunningham et al., 1997;
Korber et al., 1994; Power et al., 1994, 1995). However, the
data are far from completely conclusive. Clearly, the brain
represents an immunologically privileged region, thus
viruses replicating in the CNS are not subjected to the
immune pressures (from both T cells and antibodies) that
drive viral escape in the periphery. Additional studies, using
the SIVsmmFGb model system to examine the differences
between viral evolution in the CNS and the periphery, are
currently underway in our laboratory.
While BPZm.12 showed a macrophage-restricted phe-
notype in culture, viral replication was eventually detected
in CD3+ cells in PBMC cultures. This observation suggests
a possible defect in viral entry into the CD3+ cell popula-
tion, facilitated by the 629S mutation. Env position 629 is
in a highly conserved region of gp41 thought to be involved
in fusion and entry of virus into the host cells. Fig. 5
illustrates the current model of gp41-induced lentivirus
fusion. This model describes a conformational change in
Env from its native conformation, through a pre-hairpin
intermediate, into a hairpin structure (see Moore et al. for a
review of retroviral fusion). The envelope glycoproteins
exist as trimers of the gp41/gp120 complex on the viral
membrane. While the surface subunit, gp120, is stabilized
through its interaction with gp41, gp41 is anchored to the
membrane by its transmembrane domain and cytoplasmic
tail. The native conformation of the envelope glycoproteins
 Fig. 5. Schematic diagram of gp41-mediated lentivirus fusion. (A) The homotrimeric Env protein consists of three subunits, each containing a gp120 surface
unit (blue) and a gp41 transmembrane unit (red). After gp120 binds to CD4 and the coreceptor on the target cell, conformational changes expose the fusion
peptide on gp41. (B) The fusion peptides insert into the target cell membrane, stabilized by a triple-stranded coiled-coil formed by the three subunits’
N-terminal heptad repeats (yellow). (C) The N-terminal heptad repeats then form a six-helix bundle, folding over onto the C-terminal repeats in an antiparallel
fashion. At this point, the target cells membrane comes into close proximity to the viral membrane, initiating the process of membrane fusion. (D) Schematic
diagram of functional regions in the gp41 ectodomain. The ectodomain includes the regions from the fusion peptide to the transmembrane (TM) domain. The
blue star indicated the position of the mutation in BPZm.12, 629S, in the loop region between the heptad repeats.
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gp120 has bound to the coreceptor. When this initial
binding occurs, the conformational change in gp120 trig-
gers the gp41 fusion peptide to spring forward and embed
itself in the target cell membrane. The fusion peptide is
stabilized by the alpha-helices formed by the N-terminal
heptad repeats in the gp41 ectodomain. This phase of viral
fusion is shown in Fig. 5B.
During the pre-hairpin intermediate, the fusion peptide
contained in gp41 inserts into the target membrane. At
this point, the terminal heptad repeats in the gp41
ectodomain form coiled-coil structures of alpha-helices;
these N-terminal and C-terminal helices fold on to each
other in antiparallel fashion, three of each helix forming a
six-helix hairpin structure. The likely purpose of this
structure is to bring the target membrane in contact with
the viral membrane. The six-helix bundle is shown in
Fig. 5C.
The formation of the six-helix bundle is mediated by
the bending of the region between the two heptad repeats
(reviewed in Jelesarov and Lu, 2001; Peisajovich et al.,
2003). Amino acid 629 in the SIV gp41 is positioned
within this ‘‘loop’’ region, as shown in Fig. 5D. Thegp41 ectodomain of SIV has been crystallized and
analyzed by Ji and Lu (2000) and Liu et al. (2002),
showing several mutations in the N- or C-terminal heptad
repeats which alter the stability of the six-helix bundle.
Many studies emphasize the high degree of conservation
in these regions (Ji and Lu, 2000; Liu et al., 2002;
Malashkevich et al., 1998). However, previous literature
has not addressed mutations within the loop region. The
results presented here suggest that the change from
proline to serine at position 629 may significantly change
the tertiary conformation of the loop region and may
affect its ability to act as a bend between two antiparallel
alpha helices.
The study highlights the importance of the conserved
loop region in SIV replication in PBMC. The 629S
mutation within the loop region does not abrogate repli-
cation in macrophages, but does abrogate replication in
PBMC. The ectodomain of SIV and HIV is a region of
much current investigation, as many anti-retroviral phar-
maceuticals target the heptad repeat regions (Moore and
Doms, 2003). Future directions in this project include
determining the effect of the 629S mutation on the
structure and stability of the six-helix formation and on
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gation, including studies into the mechanism of virus
entry into macrophages and the in vivo pathogenesis of
solely macrophage-tropic clones like BPZm.12, will con-
tribute to important and timely research on the pathogen-
esis of lentiviruses and the development of anti-retroviral
pharmaceuticals.Materials and methods
Cells and culture conditions
Pig-tailed macaque peripheral blood mononuclear cells
(PBMC) were isolated from fresh whole blood by lym-
phocyte separating medium (Organon Teknika). Bulk
PBMC cultures were stimulated with concanavalin A
(Con A; 5 Ag/ml) for 3–5 days before use and main-
tained in RPMI 1640 supplemented with 5% IL-2, 10%
inactivated fetal bovine serum (Cellgro), and antibiotics.
Macrophages were derived from fresh PBMC by adher-
ence of monocytes to tissue culture wells, and were
cultured in RPMI 1640 supplemented with 15% human
AB+ serum (Nabi), 1.5 ng/ml macrophage colony-stimu-
lating factor (R&D Systems), 0.08 ng/ml granulocyte-
macrophage colony-stimulating factor (R&D Systems), 10
mM HEPES, and antibiotics at a concentration of 3 
106 PBMC per ml. Cells were washed after 4 days to
remove nonadherent cells, and then incubated for three
additional days to allow full differentiation before use.
HEK293T cells were maintained in Dulbecco’s modified
Eagle medium (DMEM) (Cellgro) supplemented with
10% FBS, 10 mM HEPES, and antibiotics. The human
T-B cell hybrid line CEMx174 was maintained in RPMI
1640 with 10% FBS, 10 mM HEPES and antibiotics.
Reverse transcriptase assays
Presence of virus in a sample was determined by
standard reverse transcriptase (RT) assay. In brief, the
activity of the viral RT enzyme was measured by its
ability to reverse-transcribe oligonucleotides in the assay
buffer. Reverse transcription incorporated the radioisotope
32P also present in the assay buffer. After incubation with
oligonucleotides and 32P, samples were transferred to
filter paper. The filter paper was washed and exposed
to photographic film (Kodak). Samples containing repli-
cating virus displayed a radiographic signal on the film.
For quantitative measurement of virus, a polyethylene
glycol-based (PEG-RT) RT assay was used. Virus was
precipitated from samples with 30% polyethylene glycol
(Sigma), and quantitated by reverse transcriptase (RT)
assay as previously described. Briefly, supernatants were
mixed with an equal volume of 30% PEG and were
incubated at 4 jC overnight. Samples were then centri-
fuged in at maximum speed for 45 min to pellet thePEG-precipitated virus. The pellet was then resuspended
and analyzed by standard RT assay; instead of exposure
to film, RT samples were quantitated by a scintillation
counter.
Cloning, PCR amplification, sequencing
Full-length molecular clones of SIVsmmFGb were gen-
erated by PCR amplification of the 3V half of the SIV genome
and combination with the previously described 5V half of
SIVsmmFGb molecular clone PGm5.3 (Novembre et al.,
1998). Genomic DNAwas prepared from frozen brain tissue
from pig-tailed macaque PZm using the Puregene kit (Gentra
Systems) and was used as a template for amplification of the
3V half of the SIV genome. PCR amplification reactions were
performed using the Expand Long Template PCR kit (Boeh-
ringer Mannheim), according to the manufacturer’s instruc-
tions. Primers for 3V half amplification were as follows:
forward (5VATG CAAGCTT AG GGG ATA TGA CTC
CAG CAG A 3V), reverse (5V AAT ACTCGAGAA AGG
GTC CTA ACA GAC CA3V). Underlined sequences repre-
sent restriction enzymes sites (HindIII and XhoI) used to
facilitate cloning. Amplification products were purified fol-
lowing agarose gel electrophoresis, digested with BclI and
XhoI. The 5V half of PGm5.3 had previously been cloned into
pGEM7ZF (Promega). To generate full-length clones, the
digested 3V halves were cloned into BclI- and XhoI-digested
5VPGm 5-pGEM 7ZF. The full-length clones were named
after the 3V half generated from brain genomic DNA (e.g.
BPZm.12).
To produce virus for in vitro analysis, full-length
molecular clones were initially transfected into CEMx174
cells with DEAE-Dextran. Reverse transcriptase (RT)
activity was monitored weekly; clones positive for RT
activity after 7–10 days were considered infectious.
Alternatively, clones were transfected into HEK293T cells
using FuGENE 6 transfection reagent (Boehringer Man-
nheim). After 48–72 h post-transfection, supernatants
were harvested and tested for RT activity. RT-positive
supernatants were used to infect stimulated pig-tailed
macaque PBMC or monocyte-derived macrophages.
PBMC and macrophages were washed after 24 h and
monitored for RT activity. Clones positive for RT activity
after 7–10 days were considered infectious.
Envelope clones were generated by PCR amplification of
the entire env gene and ligation into a plasmid vector.
Genomic DNA from the brain and mesenteric lymph node
(MLN) were purified as described above and used as a
template for the Expand High Fidelity PCR kit (Boehringer
Mannheim), according to the instructions included. Primers
for amplification were as follows: forward (5VTTT GGA
TTC ATG GGA TGT CTC GGG AAT CAG CTG CTT3V)
reverse (5VTTT GGA TCC TCA AAG GAG TGC AAG
TTC CAG TCC CTG3V). Amplified env DNA was then
cloned into plasmid vector pGEM using the pGEM-Easy kit
(Promega).
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was isolated from cell culture supernatants using the
QIAmp Viral mRNA Mini Kit (Qiagen) according to
the manufacturer’s instructions. RNA samples were then
used as templates for amplification of env regions. RT-
PCR was performed using the C. therm. Polymerase One-
Step RT-PCR System (Roche). Amplified env DNA was
then cloned into plasmid vector pGEM using the pGEM-
Easy kit (Promega).
Double-stranded plasmid DNA was sequenced at the
Emory Sequencing Core Facility. Sequence analyses
were performed using the Lasergene software package
(DNASTAR).
Growth of virus stocks
Plasmid DNA (BPZm.12, BPZm.12-629P, PBj6.6,
Novembre et al., 1993; PBj6.6-629S, and PGm5.3,
Novembre et al., 1998) was transfected into HEK293T
cells as described. Supernatants collected 24 h post-trans-
fections were used to infect pig-tailed macaque macro-
phages. After the macrophage culture supernatants tested
positive for RT activity (7–10 days), supernatants were
harvested, aliquoted, and frozen under liquid nitrogen.
For growth of BPZm.12 day 28 virus, PBMC were
infected with transfected HEK293T supernatant overnight,
then washed and maintained in culture for 21–28 days
until the PBMC cultures tested RT positive. This virus,
termed BPZm.12 day 28, was aliquoted and frozen under
liquid nitrogen.
Virus stocks were quantitated using a commercially
available p27 antigen-capture ELISA (Coulter).
Virus replication studies in PBMC and macrophages
To examine kinetics of viral replication, PBMC iso-
lated from pig-tailed macaques were stimulated with IL-2
and ConA for 3–5 days, then washed and resuspended in
media containing IL-2. Infections were initiated by incu-
bating 2  107 PBMC with virus overnight (2 or 10 ng
of p27 equivalents, as specified for each experiment, in a
total of 3 ml media). PBMC were then washed free of
nonabsorbed virus and maintained in fresh media con-
taining IL-2. Samples of supernatant were harvested on
days 3, 7, 10, 14, 17, 21, 24, and 28. Supernatants were
stored at 70 jC. At the conclusion of each study, RT
activity was quantitated by PEG-RT assay.
Monocyte-derived macrophages were differentiated as
described above. Cells were cultured in 24-well microtiter
plates. Nonadherent cells were washed off after 4 days.
After 7 days, infection was initiated by incubating macro-
phages overnight with 2 or 10 ng p27 equivalents of
virus (as specified for each experiment) in 500-Al total
volume. Cells were washed the next day and maintained
in macrophage media as described. On days 3, 7, 10, and
14, supernatants were harvested. Supernatants were storedat 70 jC. At the conclusion of the study, RT activity
was quantitated by PEG-RT assay.
Virus replication in a cell line
CEMx174 cells were maintained as described above.
Virus infection was initiated by incubating overnight 1 
107 cells with 10 ng p27 equivalent of virus. Cells were
then washed and resuspended in appropriate media.
Samples of supernatants were harvested on days 3, 7,
10, 14, 17, 21, 24, and 28. Supernatants were stored at
70 jC. At the conclusion of the study, RT activity was
quantitated by PEG-RT assay.
Immunomagnetic cell separation
Immunomagnetic separation of cells was performed
using the AutoMACS system (Miltenyi). Bulk PBMC
were incubated with anti-CD3q PE antibody (Pharmin-
gen), then with anti-PE magnetic beads (Miltenyi). The
labeled cells were then applied to the magnetic column
contained in the AutoMACS apparatus, which retained
CD3+ cells. After CD3-negative cells were collected,
CD3+ cells were eluted from the column. CD3+ and
CD3 populations, as well as bulk PBMC, were ana-
lyzed by flow cytometry. Bulk PBMC were efficiently
separated using the anti-CD3 antibody at a titer of 1 ml
anti-CD3qPE/108 PBMC. To deplete PBMC of CD14+
cells, PBMC were incubated with anti-CD14-PE (My4-
RD clone, Coulter), then with anti-PE magnetic beads,
before separation on the AutoMACS magnetic column.
Both CD14+ and CD14 populations, as well as bulk
PBMC, were analyzed by flow cytometry. CD14+ cells
were efficiently removed from PBMC by using the anti-
CD14 antibody at a titer of 5 Al/107 PBMC.
Site-directed mutagenesis
The QuikChange site-directed mutagenesis kit (Strata-
gene) was used to change one nucleotide in BPZm.12 and
PBj6.6. Subclones containing the 3V half of these clones were
used as the parental strand. Primers for BPZm.12 629P were
as follows: forward (5VCCCCTCCCA CTTATGTT-
CAGCAGATCCCTATCC3V) and reverse complement.
Primers for PBj6.6 629S were as follows: (5VGGCAGG-
GGCAGGTCTGCCACACTACTGTACCATGGTCAAAT-
GACA C3V) and reverse complement. Underlined are the
codons differing from the parental clones. According to
directions of the manufacturer, the PCR products were
digested with DpnI for 1 h to eliminate parental plasmid;
the digestion products were used to transform XL-10 Gold
cells (Stratagene). Mutagenesis was confirmed by sequenc-
ing at the Emory DNA Sequencing Core Facility. Mutant
subclones and parental 5V subclones were digested with BclI
and XhoI and ligated to generate full-length clones with one
nucleotide change.
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The entire sequence of the 3V half of BPZm.12 has
been submitted to GenBank under the accession number
AY603050.
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